RankAlpha logo
Back to Rankings

NKTR

Nektar TherapeuticsB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
NKTR vs peer average
77/100
NKTR vs. peer average (B vs. D)
Grade spread
A 2 · C 1 · D 3 · F 4
Graded peers loaded
Coverage
10 graded
91% of tracked

Peer overview

ELVN is the first available peer comparator.

Small-cap clinical-stage biotech with valuation driven by pipeline milestones rather than current revenue; useful comparator for event-driven re-rating behavior.

Peer source comes from the stored AI memo or peer model
Grades and factor rows use RankAlpha API data when available
Missing peer scores remain blank instead of being estimated
Side-by-side comparison keeps the data contract visible
Top peerELVNEnliven Therapeutics
NKTR
Nektar Therapeutics
ELVN
Enliven Therapeutics
Grade
B
F
Momentum
50
89
Value
41
41
Sentiment
76
28
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Defensive

Grade position vs ELVN

NKTR / ELVN
Grade Position
Above peers
NKTR vs. peer average (B vs. D)
77/100
Momentum
50
ELVN
Value
41
NKTR
Sentiment
76
NKTR

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs NKTR
1
ELVN
ELVN
F
20/100
+3
2
CMPX
CMPX
C
60/100
+1
3
ESPR
ESPR
-
-
-
4
PHVS
Pharvaris NV Common
D
40/100
+2
5
COAG
Hemab Therapeutics Holdings Inc Common
D
40/100
+2
ELVN is the first peer returned for this comparison set.